Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies
NCT: NCT04523376 · COMPLETED
Brief Summary
This is a single arm pilot study of peripheral stem cell transplantation (PSCT) with ex vivo t-cell receptor alpha beta+(TCRαβ+) T cell and cluster of differentiation 19+ beta (CD19+ B) cell depletion of unrelated donor (URD) grafts using the CliniMACS device in patients with sickle cell disease (SCD) and beta thalassemia major (BTM).
Frequently Asked Questions
What is Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies?
Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies is a clinical trial registered under NCT04523376. Current status: COMPLETED.
What is the status of NCT04523376?
The current status of NCT04523376 (Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies) is: COMPLETED.
When did Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies start?
Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies started on 2020-05-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.